Search research articles
Contact Us
Filters
Showing results (41-50 of 74) with videos related to
Page
of 8
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 23, 2012
Retinol-binding protein 4 is an independent factor associated with triglycerides and a determinant of very low-density lipoprotein-apolipoprotein B100 catabolism in type 2 diabetes mellitus
Bruno Vergès, Boris Guiu, Jean Pierre Cercueil, et al.
Diabetes Research and Clinical Practice
|
February 3, 2025
Evolution of myocardial steatosis in high cardiovascular risk T2DM patients treated by GLP1 receptor agonists: LICAS study
Lina Houbachi, Paul Michael Walker, Isabelle Fournel, et al.
Diabetes & Metabolism
|
January 19, 2026
Bedside amputation surgery for isolated toe necrosis in diabetes units as an alternative to conventional amputation in surgery units
Florine Féron, Jean-Philippe Kevorkian, Jean-Baptiste Julla, et al.
Clinical Endocrinology
|
January 15, 2014
Circulating apelin is increased in patients with type 1 or type 2 diabetes and is associated with better glycaemic control
Marana Habchi, Laurence Duvillard, Vanessa Cottet, et al.
Acta Diabetologica
|
May 16, 2015
GCKR polymorphism influences liver fat content in patients with type 2 diabetes
Jean-Michel Petit, David Masson, Boris Guiu, et al.
Atherosclerosis
|
September 11, 2012
Liver fat content is associated with an increase in cholesterol synthesis independent of statin therapy use in patients with type 2 diabetes
Marie-Claude Brindisi, Boris Guiu, Laurence Duvillard, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
July 21, 2018
Liraglutide Reduces Postprandial Hyperlipidemia by Increasing ApoB48 (Apolipoprotein B48) Catabolism and by Reducing ApoB48 Production in Patients With Type 2 Diabetes Mellitus
Bruno Vergès, Laurence Duvillard, Jean Paul Pais de Barros, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 9, 2009
Nonalcoholic fatty liver is not associated with carotid intima-media thickness in type 2 diabetic patients
Jean Michel Petit, Boris Guiu, Beatrice Terriat, et al.
Acta Diabetologica
|
May 15, 2023
Real-world treatment patterns and diagnosis of charcot foot in franco-belgian diabetic foot expert centers (The EPiChar Study)
Carole-Anne Julien, Georges Ha Van, Jocelyne M'Bemba, et al.
Diabetes & Metabolism
|
May 6, 2024
Plasma 16:0 ceramide as a marker of cardiovascular risk estimated by carotid intima-media thickness in people with type 2 diabetes
Damien Denimal, Laurence Duvillard, Sarah Béland-Bonenfant, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 74) with videos related to
Sort By:
Page
of 8
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 23, 2012
Retinol-binding protein 4 is an independent factor associated with triglycerides and a determinant of very low-density lipoprotein-apolipoprotein B100 catabolism in type 2 diabetes mellitus
Bruno Vergès, Boris Guiu, Jean Pierre Cercueil, et al.
Diabetes Research and Clinical Practice
|
February 3, 2025
Evolution of myocardial steatosis in high cardiovascular risk T2DM patients treated by GLP1 receptor agonists: LICAS study
Lina Houbachi, Paul Michael Walker, Isabelle Fournel, et al.
Diabetes & Metabolism
|
January 19, 2026
Bedside amputation surgery for isolated toe necrosis in diabetes units as an alternative to conventional amputation in surgery units
Florine Féron, Jean-Philippe Kevorkian, Jean-Baptiste Julla, et al.
Clinical Endocrinology
|
January 15, 2014
Circulating apelin is increased in patients with type 1 or type 2 diabetes and is associated with better glycaemic control
Marana Habchi, Laurence Duvillard, Vanessa Cottet, et al.
Acta Diabetologica
|
May 16, 2015
GCKR polymorphism influences liver fat content in patients with type 2 diabetes
Jean-Michel Petit, David Masson, Boris Guiu, et al.
Atherosclerosis
|
September 11, 2012
Liver fat content is associated with an increase in cholesterol synthesis independent of statin therapy use in patients with type 2 diabetes
Marie-Claude Brindisi, Boris Guiu, Laurence Duvillard, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
July 21, 2018
Liraglutide Reduces Postprandial Hyperlipidemia by Increasing ApoB48 (Apolipoprotein B48) Catabolism and by Reducing ApoB48 Production in Patients With Type 2 Diabetes Mellitus
Bruno Vergès, Laurence Duvillard, Jean Paul Pais de Barros, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 9, 2009
Nonalcoholic fatty liver is not associated with carotid intima-media thickness in type 2 diabetic patients
Jean Michel Petit, Boris Guiu, Beatrice Terriat, et al.
Acta Diabetologica
|
May 15, 2023
Real-world treatment patterns and diagnosis of charcot foot in franco-belgian diabetic foot expert centers (The EPiChar Study)
Carole-Anne Julien, Georges Ha Van, Jocelyne M'Bemba, et al.
Diabetes & Metabolism
|
May 6, 2024
Plasma 16:0 ceramide as a marker of cardiovascular risk estimated by carotid intima-media thickness in people with type 2 diabetes
Damien Denimal, Laurence Duvillard, Sarah Béland-Bonenfant, et al.
Page
of 8